5 Simple Statements About Myositis Therapy center in vasant Kunj Explained
Rituximab can be a chimeric monoclonal antibody in opposition to the CD20 antigen expressed over the surface area of B lymphocytes leading to their depletion within the peripheral blood. numerous case reviews, situation series and open-label trials have suggested a beneficial result of rituximab in clients with refractory myositis (current overview